- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有3家主力机构披露2025-12-31报告期持股数据，持仓量总计475.78万股，占流通A股0.32%
- 波段诊断：
-
技术面诊股
诊断结果：7.3技术面打败了61%的股票
技术面评分前10的股票
近期的平均成本为15.29元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为15.29元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.29","date":1769329995,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑输行业平均水平。
[{"date":"2026.01.26","stock":"0.85","trade":"1.36","ind":"-0.09"},{"date":"2026.01.23","stock":"0.79","trade":"0.94","ind":"0.33"},{"date":"2026.01.22","stock":"0.20","trade":"0.49","ind":"0.14"},{"date":"2026.01.21","stock":"-0.26","trade":"0.31","ind":"0.08"},{"date":"2026.01.20","stock":"0.26","trade":"0.50","ind":"-0.01"},{"date":"2026.01.19","stock":"0.33","trade":"0.52","ind":"0.29"},{"date":"2026.01.16","stock":"-1.31","trade":"-0.85","ind":"-0.26"},{"date":"2026.01.15","stock":"-0.46","trade":"-0.72","ind":"-0.33"},{"date":"2026.01.14","stock":"-0.26","trade":"-0.40","ind":"-0.31"},{"date":"2026.01.13","stock":"0.46","trade":"0.86","ind":"-0.64"},{"date":"2026.01.12","stock":"-0.13","trade":"0.28","ind":"1.09"},{"date":"2026.01.09","stock":"0.20","trade":"0.77","ind":"0.92"},{"date":"2026.01.08","stock":"0.00","trade":"0.84","ind":"-0.07"},{"date":"2026.01.07","stock":"0.07","trade":"-0.50","ind":"0.05"},{"date":"2026.01.06","stock":"0.07","trade":"0.58","ind":"1.50"},{"date":"2026.01.05","stock":"1.26","trade":"2.21","ind":"1.38"},{"date":"2025.12.31","stock":"0.00","trade":"-0.42","ind":"0.09"},{"date":"2025.12.30","stock":"-0.20","trade":"-0.80","ind":"-0.00"},{"date":"2025.12.29","stock":"-1.24","trade":"-1.56","ind":"0.04"},{"date":"2025.12.26","stock":"-0.07","trade":"-0.59","ind":"0.10"},{"date":"2025.12.25","stock":"0.46","trade":"0.49","ind":"0.47"}]
天士力,上证指数,中药指数
压力支撑
该股压力位为15.26元，支撑位为15.13元。
[{"text":"\u538b\u529b\u4f4d","value":"15.26","date":1769356800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.13","date":1769356800,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.9资金面打败了75%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：01月26日 20:31
| 机构今日流向(万元) | 1566.69 | 机构5日流向(万元) | -1657.84 |
| 机构10日流向(万元) | -10118.98 | 机构20日流向(万元) | -14730.37 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少88694.64万股，其中基金净增仓1家，主力净减仓373家，暂未发现中长期投资价值。
截止2025-12-31，共3家主力机构（基金3家），持仓量总计475.78万股，占流通A股0.32%
其中，基金持仓与2025-06-30相比：
增仓：1家 ，增持 94.06万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：373家 ，原持有88788.7万股
其中，基金持仓与2025-06-30相比：
增仓：1家 ，增持 94.06万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：373家 ，原持有88788.7万股
消息面诊股
诊断结果：5.5消息面打败了61%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 券商观点|医药生物行业报告：国家统计局公布各项经济
2026-01-26 - 【私募调研记录】林园投资调研华润三九
2026-01-26 - 天士力：1月23日获融资买入923.55万元
2026-01-24 - 千亿糖尿病药市场，谁主沉浮？
2026-01-23 - 行业周报|中药指数涨2.80%, 跑赢上证指数1.
2026-01-23 - 天士力：1月22日获融资买入748.19万元
2026-01-23 - 重磅利好落地！1月22日九部门促医药零售高质量发展
2026-01-22 - 天士力：1月21日获融资买入982.17万元
2026-01-22 - 天士力医药集团亮相华润科技成果展
2026-01-21 - 天士力：1月20日获融资买入692.97万元
2026-01-21
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2025-12-27 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-26 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-12-10 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-10 |
| 一般消息 | 高管变动 | 工作调整 | 2025-12-09 |
| 利好 | 分红转增 | 10派2.1元(含税) | 2025-08-16 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-16 |
| 一般消息 | 高管变动 | 由于工作变动原因 | 2025-08-01 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 高管变动 | 委员会变更 | 2025-04-15 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-04-01 |
| 一般消息 | 高管变动 | 因工作原因 | 2025-03-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-18 |
| 利好 | 分红转增 | 10派2元(含税) | 2025-02-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-02-25 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.8行业面打败了94%的股票
中药行业最新资金流向
近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑赢大盘。
[{"date":"2026.01.26","price":"-0.09","value":"1.36"},{"date":"2026.01.23","price":"0.33","value":"0.94"},{"date":"2026.01.22","price":"0.14","value":"0.49"},{"date":"2026.01.21","price":"0.08","value":"0.31"},{"date":"2026.01.20","price":"-0.01","value":"0.50"},{"date":"2026.01.19","price":"0.29","value":"0.52"},{"date":"2026.01.16","price":"-0.26","value":"-0.85"},{"date":"2026.01.15","price":"-0.33","value":"-0.72"},{"date":"2026.01.14","price":"-0.31","value":"-0.40"},{"date":"2026.01.13","price":"-0.64","value":"0.86"},{"date":"2026.01.12","price":"1.09","value":"0.28"},{"date":"2026.01.09","price":"0.92","value":"0.77"},{"date":"2026.01.08","price":"-0.07","value":"0.84"},{"date":"2026.01.07","price":"0.05","value":"-0.50"},{"date":"2026.01.06","price":"1.50","value":"0.58"},{"date":"2026.01.05","price":"1.38","value":"2.21"},{"date":"2025.12.31","price":"0.09","value":"-0.42"},{"date":"2025.12.30","price":"-0.00","value":"-0.80"},{"date":"2025.12.29","price":"0.04","value":"-1.56"},{"date":"2025.12.26","price":"0.10","value":"-0.59"},{"date":"2025.12.25","price":"0.47","value":"0.49"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 23.70% | -3.60% | 5.2分 |
| 2 | 沃华医药 | 21.96% | -0.65% | 6.9分 |
| 3 | 粤万年青 | 19.09% | 7.41% | 5.7分 |
| 4 | 众生药业 | 17.65% | 5.81% | 6.8分 |
| 5 | 特一药业 | 17.56% | 12.83% | 6.4分 |
| 6 | 盘龙药业 | 16.37% | -1.22% | 6.2分 |
| 8 | 恩威医药 | 14.74% | 4.99% | 6.3分 |
| 10 | 康惠股份 | 13.75% | 9.08% | 5.9分 |
| 12 | 方盛制药 | 10.33% | 2.97% | 6.6分 |
| 14 | 上海凯宝 | 8.65% | 5.71% | 6.3分 |
| 16 | 仁和药业 | 7.24% | 1.80% | 5.6分 |
| 18 | 康缘药业 | 6.54% | 2.27% | 6.1分 |
| 20 | 益盛药业 | 6.39% | 3.61% | 5.8分 |
| 22 | 步长制药 | 5.99% | 4.16% | 6.3分 |
| 24 | 新天药业 | 5.73% | 2.79% | 5.6分 |
| 26 | 三力制药 | 5.56% | 4.33% | 6.1分 |
| 28 | 吉林敖东 | 5.06% | 2.67% | 6.1分 |
| 30 | 汉森制药 | 4.75% | 3.52% | 6.4分 |
| 32 | 亚宝药业 | 4.51% | 2.96% | 6.5分 |
| 34 | 太龙药业 | 3.75% | 8.94% | 6.7分 |
| 36 | 康恩贝 | 3.53% | 3.76% | 6.4分 |
| 38 | 佛慈制药 | 3.24% | 3.93% | 5.8分 |
| 40 | 古汉医药 | 3.17% | -0.42% | 6.2分 |
| 42 | 太极集团 | 2.97% | 1.57% | 5.3分 |
| 44 | 振东制药 | 2.35% | 0.49% | 5.1分 |
| 46 | 羚锐制药 | 2.04% | 3.11% | 6.5分 |
| 48 | 康美药业 | 1.55% | 1.55% | 5.8分 |
| 50 | 金花股份 | 1.26% | 1.00% | 5.7分 |
| 52 | 天士力 | 0.52% | 1.85% | 6.4分 |
| 54 | 华森制药 | 0.00% | 2.70% | 5.3分 |
| 56 | 广誉远 | -0.76% | 1.61% | 5.3分 |
| 58 | 云南白药 | -1.04% | -0.09% | 4.7分 |
| 60 | 葵花药业 | -1.34% | 0.14% | 3.5分 |
| 62 | 同仁堂 | -4.33% | -2.59% | 4.3分 |
| 64 | 片仔癀 | -5.84% | -4.48% | 3.9分 |
| 66 | ST百灵 | -9.94% | 1.87% | 5.5分 |
| 68 | ST葫芦娃 | -20.25% | 1.59% | 4.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 21/109 ， 18/109。
[{"date":"2025-09-30","value":"8.13","vol":"4.74"},{"date":"2025-06-30","value":"6.38","vol":"3.98"},{"date":"2025-03-31","value":"2.64","vol":"2.21"},{"date":"2024-12-31","value":"7.87","vol":"4.80"},{"date":"2024-09-30","value":"6.72","vol":"2.91"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
8.13 | 6.38 | 2.64 | 7.87 | 6.72 |
| 行业(%) | 4.74 | 3.98 | 2.21 | 4.80 | 2.91 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"66.99","vol":"52.31"},{"date":"2025-06-30","value":"67.37","vol":"52.86"},{"date":"2025-03-31","value":"66.61","vol":"53.38"},{"date":"2024-12-31","value":"67.14","vol":"52.74"},{"date":"2024-09-30","value":"66.80","vol":"53.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
66.99 | 67.37 | 66.61 | 67.14 | 66.80 |
| 行业(%) | 52.31 | 52.86 | 53.38 | 52.74 | 53.11 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 28/109 ， 19/109。
[{"date":"2025-09-30","value":"-2.35","vol":"-7.31"},{"date":"2025-06-30","value":"-1.91","vol":"-7.31"},{"date":"2025-03-31","value":"0.30","vol":"-7.18"},{"date":"2024-12-31","value":"-2.03","vol":"-7.35"},{"date":"2024-09-30","value":"-1.66","vol":"-5.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-2.35 | -1.91 | 0.30 | -2.03 | -1.66 |
| 行业(%) | -7.31 | -7.31 | -7.18 | -7.35 | -5.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"16.88","vol":"-2.54"},{"date":"2025-06-30","value":"16.97","vol":"2.98"},{"date":"2025-03-31","value":"6.47","vol":"-37.19"},{"date":"2024-12-31","value":"-10.78","vol":"-146.29"},{"date":"2024-09-30","value":"-18.41","vol":"61.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
16.88 | 16.97 | 6.47 | -10.78 | -18.41 |
| 行业(%) | -2.54 | 2.98 | -37.19 | -146.29 | 61.78 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 21/109 ， 41/109。
[{"date":"2025-09-30","value":"0.42","vol":"0.35"},{"date":"2025-06-30","value":"0.28","vol":"0.24"},{"date":"2025-03-31","value":"0.14","vol":"0.12"},{"date":"2024-12-31","value":"0.54","vol":"0.50"},{"date":"2024-09-30","value":"0.39","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.42 | 0.28 | 0.14 | 0.54 | 0.39 |
| 行业(次) | 0.35 | 0.24 | 0.12 | 0.50 | 0.37 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.33","vol":"1.73"},{"date":"2025-06-30","value":"0.86","vol":"1.18"},{"date":"2025-03-31","value":"0.41","vol":"0.61"},{"date":"2024-12-31","value":"1.61","vol":"2.42"},{"date":"2024-09-30","value":"1.24","vol":"1.81"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.33 | 0.86 | 0.41 | 1.61 | 1.24 |
| 行业(次) | 1.73 | 1.18 | 0.61 | 2.42 | 1.81 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"4.11","vol":"9.48"},{"date":"2025-06-30","value":"51.58","vol":"20.05"},{"date":"2025-03-31","value":"-17.63","vol":"-0.23"},{"date":"2024-12-31","value":"40.51","vol":"15.64"},{"date":"2024-09-30","value":"14.50","vol":"5.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 4.11 | 51.58 | -17.63 | 40.51 | 14.50 |
| 行业 | 9.48 | 20.05 | -0.23 | 15.64 | 5.86 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.09","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.12","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.09 | - | 1.12 | - |
| 行业 | 0.00 | 1.02 | 0.00 | 1.45 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 52/109 ， 54/109。
[{"date":"2025-09-30","value":"3.82","vol":"3.05"},{"date":"2025-06-30","value":"3.31","vol":"2.90"},{"date":"2025-03-31","value":"3.00","vol":"2.99"},{"date":"2024-12-31","value":"3.11","vol":"2.88"},{"date":"2024-09-30","value":"2.70","vol":"3.25"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.82 | 3.31 | 3.00 | 3.11 | 2.70 |
| 行业 | 3.05 | 2.90 | 2.99 | 2.88 | 3.25 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.07","vol":"2.21"},{"date":"2025-06-30","value":"2.64","vol":"2.13"},{"date":"2025-03-31","value":"2.30","vol":"2.22"},{"date":"2024-12-31","value":"2.34","vol":"2.11"},{"date":"2024-09-30","value":"2.16","vol":"2.43"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.07 | 2.64 | 2.30 | 2.34 | 2.16 |
| 行业 | 2.21 | 2.13 | 2.22 | 2.11 | 2.43 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 55/109 ， 56/109。
[{"date":"2025-09-30","value":"16.43","vol":"33.12"},{"date":"2025-06-30","value":"18.43","vol":"33.87"},{"date":"2025-03-31","value":"19.01","vol":"33.29"},{"date":"2024-12-31","value":"19.13","vol":"34.05"},{"date":"2024-09-30","value":"22.67","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
16.43 | 18.43 | 19.01 | 19.13 | 22.67 |
| 行业(%) | 33.12 | 33.87 | 33.29 | 34.05 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.20","vol":"0.75"},{"date":"2025-06-30","value":"0.23","vol":"0.74"},{"date":"2025-03-31","value":"0.24","vol":"0.72"},{"date":"2024-12-31","value":"0.24","vol":"0.75"},{"date":"2024-09-30","value":"0.30","vol":"3.20"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.20 | 0.23 | 0.24 | 0.24 | 0.30 |
| 行业(%) | 0.75 | 0.74 | 0.72 | 0.75 | 3.20 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 光大证券 | 2026-01-18 | 买入 | 买入 |
| 中信证券 | 2025-11-06 | 买入 | |
| 中信建投证券 | 2025-11-03 | 买入 | |
| 招商证券 | 2025-11-02 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"23.59","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-2.57","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"10.71","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"9.56","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"11.57","blueLineValue":"0.77","type":"YC"}]